Skip to content

Gross margin at other companies

Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
51.9%-1.6pp
Pacific Biosciences of California logo
Pacific Biosciences of CaliforniaPACB
37.5%+21.3pp
iRadimed logo
iRadimedIRMD
76.8%-0.1pp
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
36.3%+1.7pp
Lifecore Biomedical, Inc. logo
Lifecore Biomedical, Inc.LFCR
31.3%-1.4pp
Fulgent Genetics, Inc. logo
Fulgent Genetics, Inc.FLGT
38.7%-0.1pp

Other financials

Income statement

See full
Revenue$8.0M+11.1%
Gross profit$371.0K-8.2%
Operating income-$13.9M-18.8%
Net income-$14.3M-26.7%
EPS (diluted)-$0.31-19.2%

Balance sheet

See full
Cash & equivalents$14.1M-26.8%
Total debt$23.8M+301%
Total equity$20.4M-68.9%
Total assets$62.4M-27.0%

Cash flow

See full
Operating cash flow-$15.1M-66.1%
CapEx$394.0K+23.5%
Free cash flow-$15.5M-64.7%

Valuation

See full
Market cap$86.19M-43.8%
Enterprise value$95.86M-31.7%
P/S2.5×-2.6×

Profitability

See full
Operating margin-144.2%-12.7pp
Net margin-145.8%-5.0pp
FCF margin-110.5%-14.9pp

Returns & leverage

See full
Return on equity-116.7%-620pp
Debt / equity1.2×+1.1×
Current ratio2.6×-2.0×